| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |